Effects of X-radiation on lung cancer cells: the interplay between oxidative stress and P53 levels Fernando MendesTiago SalesManuel Santos Rosa Original Paper 18 November 2015 Article: 266
Expressional profiles of transcription factors in the progression of Helicobacter pylori-associated gastric carcinoma based on protein/DNA array analysis Ting-Zi HuLi-Hua HuangXiao-Xia Jiang Original Paper 12 November 2015 Article: 265
PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization Puxiongzhi WangJingkun ZhaoMinhua Zheng Original Paper 09 November 2015 Article: 264
Inflammation-induced oxidative stress in breast cancer patients Aline Tengan RoqueRafael Zuppardo GambeloniJuliana Carvalho Santos Short Communication 05 November 2015 Article: 263
Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants? Zhao-Hua ShenDong-Feng ZengPei-Yan Kong Review Paper 02 November 2015 Article: 262
Comparison of efficacy of neoadjuvant chemotherapy FEC 100 and Docetaxel 75 versus AC and Docetaxel in locally advanced breast cancer: a randomized clinical study K. M. DhanrajB. DubashiSunu Lazar Cyriac Original Paper 31 October 2015 Article: 261
Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC) Ting ShuangMin WangCong Shi Original Paper 31 October 2015 Article: 260
Leveraging growth factor induced macropinocytosis for targeted treatment of lung cancer Raul IglesiasPiyush Koria Original Paper 30 October 2015 Article: 259
The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116 Daiva DabkevicieneVioleta JonusieneAusra Sasnauskiene Original Paper 30 October 2015 Article: 258
Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma A. C. MamedeS. GuerraM. F. Botelho Original Paper 27 October 2015 Article: 257
Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer Huiwei QiSen JiangJie Zhang Original Paper 23 October 2015 Article: 256